drugset / Trial / NCT00267683
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Japan. This is a clinical trial to study the efficacy and safety of thrice daily Insulin Aspart compared to Glibenclamide in type 2 diabetic patients.
Timeline
- Start
- 2005-12
- Primary completion
- 2006-04
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glyburide | Small molecule | — | — |
| Subject | insulin aspart | Protein / enzyme biologic | — | — |